Company Intelligence
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods…
Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Computational antibody design
Macromoltek was founded in 2018 per the company profile source on file.
SourceAn evergreen landscape report of 14 verified AI companies in Healthcare covered on Brel Digital, grounded in company…
View ReportA verified landscape of AI companies on Brel Digital tagged for the Clinical Documentation use case, citing official…
View ReportA verified landscape of AI companies on Brel Digital tagged for Generative AI, citing official sources already on…
View ReportA verified landscape of AI companies on Brel Digital tagged for Large Language Models (LLMs), citing official sources…
View ReportEvergreen insight listing verified Brel companies tagged for Medical Imaging with official sources.
Read InsightEvergreen snapshot of verified AI companies in Healthcare on Brel Digital.
Read InsightEvergreen insight linking verified Brel companies tagged for Medical Imaging, with official sources on file.
Read InsightEvergreen insight linking verified Brel companies tagged for Ambient Scribing, with official sources on file.
Read InsightMacromoltek: Revolutionizing antibody design.
Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.
Request a correction if you represent this company or believe information is inaccurate.
